LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico

Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access routes, and payer expectations vary across the region?For global market access teams planning for launch in Latin America (LATAM), understanding the diversity and complexity of this region is essential. Healthcare systems vary significantly between markets, regulatory and payer expectations differ, and health technology assessment (HTA) processes continue to evolve. These differences create both opportunities and challenges for Pharma and Medtech companies preparing evidence, developing global plans, and equipping local affiliates with the right materials to secure access.In this episode, Louise Maddison (Senior Consultant – Global Pricing and Market Access, Petauri Evidence) interviewed four regional experts: For Argentina: Eleonora Aiello (CEO at Ceibo Health Consulting) For Brazil: Alessandra Calabró (Independent expert in market access and government affairs) For Colombia: María Fernanda Escobar (Principal Advisor, InnovaSalud) For Mexico: Fernando del Río (Partner at InnovaSalud, GP at XB Ventures)Together, they unpack the access landscape in their countries, sharing experience‑based insight to help global teams refine evidence plans and align global materials to local payer expectations.Together, they explore:Variation in healthcare systems, regulatory structures, and payer landscapes across LATAMHTA landscape in key markets and the influence of bodies such as CONITEC in Brazil, IETS in Colombia, CENETEC in Mexico, and ANEFiTS in ArgentinaDifferences in evidence expectations, including clinical, economic, and real‑world data requirementsHow global dossiers, value messages, and evidence packages can better support affiliates engaging with local payersOpportunities and challenges for introducing Pharma and Medtech innovations into LATAM marketsFuture policy, regulatory, and reimbursement developments to monitor across the regionThis episode was first broadcast as a live webinar on Thursday 19th March 2026. For more information about this webinar see: https://petauri.com/insights/latam-market-access-unlocked/For support with market access strategy and global launch, please reach out to [email protected] to our newsletter to hear more  news, insights and events from Petauri Evidence